Question 1

Is END Melanoma a tax-exempt 501(c)(3)?

Accepted Answer

Yes — END Melanoma is recognised by the IRS as a 501(c)(3) organisation (EIN 45-0594179). The IRS recognised END Melanoma as tax-exempt in July 2009.

Question 2

What is END Melanoma's EIN?

Accepted Answer

END Melanoma's Employer Identification Number (EIN) is 45-0594179. The EIN was assigned by the IRS in July 2009. Donors and grantmakers use the EIN to verify tax-exempt status with the IRS.

Question 3

What does END Melanoma do?

Accepted Answer

The organization is orgnized to pursue a b road mission of improving the lives of those afflicted or impacted by all stages of Melanoma. The foundation will support efforts to find a cure for melnoma cancer; improve survival of Melanoma; and fund research.

Question 4

Where is END Melanoma located?

Accepted Answer

END Melanoma is located at P O BOX 790033, Charlotte, NC, 28206.

Question 5

When was END Melanoma founded or recognised by the IRS?

Accepted Answer

END Melanoma was recognised by the IRS as a tax-exempt organisation in July 2009. The IRS ruling date is the earliest authoritative date available for most US nonprofits.

Question 6

What is END Melanoma's annual revenue?

Accepted Answer

On its most recent Form 990 (fiscal year 2025), END Melanoma reported $117K in total revenue and $12K in total expenses.

Question 7

Has END Melanoma been auto-revoked by the IRS?

Accepted Answer

No — END Melanoma (EIN 45-0594179) does not appear on the IRS Auto-Revocation List. Givalgo Discover cross-references the IRS Auto-Revocation List on every profile load; if status changes, this page reflects it.

Question 8

Is END Melanoma listed in IRS Publication 78?

Accepted Answer

Yes — END Melanoma is listed in IRS Publication 78 as an organisation eligible to receive tax-deductible charitable contributions. Pub 78 status is the canonical IRS signal that donations to an org are deductible.

Loading profile…

END Melanoma

Due Diligence Summary

AI Organization Overview

Mission Statement

Organization Details

Contact

Financial Snapshot

Location

Governance

Frequently asked questions about END Melanoma